drugset / Trial / NCT04444011
Pharmacokinetic Interactions of Quadruple Therapy With Anaprazole/Amoxicilin/Clarithromycin/Bismuth
RandomizedCrossoverOpen-labelTreatment
Summary
A single-center, randomized, open-label, crossover study to evaluate the pharmacokinetic drug-drug interaction and safety of the quadruple therapy with Anaprazole 20mg/Amoxicilin 1000mg/Clarithromycin 500mg/Bismuth Potassium Citrate 0.6g in healthy Chinese male subjects.
Timeline
- Start
- 2020-07-01
- Primary completion
- 2020-09-30
- Completion
- 2020-10-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amoxicillin | Other / unclassified | 1000 mg | Oral |
| Subject | Anaprazole | Other / unclassified | 20 mg | Oral |
| Subject | Bismuth Potassium Citrate | Unknown | 0.6 g | Oral |
| Subject | Clarithromycin | Small molecule | 500 mg | Oral |
Indications
No indication recorded.